Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Molinaro

Showing results (131-140 of 208) with videos related to

Pageof 21
Sort By:
American Journal of Human Genetics|May 13, 2022
The immunogenetics of viral antigen response is associated with subtype-specific glioma risk and survivalGeno Guerra, Linda Kachuri, George Wendt, et al.
Neuro-Oncology Advances|September 9, 2024
Oligodendroglioma patient survival is associated with circulating B-cells and ageJennie W Taylor, Gayathri Warrier, Helen M Hansen, et al.
Neurosurgery|July 19, 2016
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional ExperienceBrandon S Imber, Ishan Kanungo, Steve Braunstein, et al.
Nature Communications|January 14, 2025
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survivalLinda Kachuri, Geno A Guerra, Taishi Nakase, et al.
Journal of Neuro-Oncology|June 14, 2021
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendrogliomaNancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology|March 14, 2022
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implicationsEsraa Mohamed, Anupam Kumar, Yalan Zhang, et al.
Journal of Neuro-Oncology|May 1, 2020
The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollmentRamin A Morshed, Sheantel J Reihl, Annette M Molinaro, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2025
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancerMd Saiful Islam Saif, Kartik Sehgal, Ze Zhang, et al.
Clinical Epigenetics|February 11, 2017
Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survivalJohn K Wiencke, Devin C Koestler, Lucas A Salas, et al.
Clinical Epigenetics|October 29, 2022
Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarkerEmily Tang, John K Wiencke, Gayathri Warrier, et al.
Pageof 21

Showing results (131-140 of 208) with videos related to

Sort By:
Pageof 21
American Journal of Human Genetics|May 13, 2022
The immunogenetics of viral antigen response is associated with subtype-specific glioma risk and survivalGeno Guerra, Linda Kachuri, George Wendt, et al.
Neuro-Oncology Advances|September 9, 2024
Oligodendroglioma patient survival is associated with circulating B-cells and ageJennie W Taylor, Gayathri Warrier, Helen M Hansen, et al.
Neurosurgery|July 19, 2016
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional ExperienceBrandon S Imber, Ishan Kanungo, Steve Braunstein, et al.
Nature Communications|January 14, 2025
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survivalLinda Kachuri, Geno A Guerra, Taishi Nakase, et al.
Journal of Neuro-Oncology|June 14, 2021
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendrogliomaNancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology|March 14, 2022
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implicationsEsraa Mohamed, Anupam Kumar, Yalan Zhang, et al.
Journal of Neuro-Oncology|May 1, 2020
The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollmentRamin A Morshed, Sheantel J Reihl, Annette M Molinaro, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2025
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancerMd Saiful Islam Saif, Kartik Sehgal, Ze Zhang, et al.
Clinical Epigenetics|February 11, 2017
Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survivalJohn K Wiencke, Devin C Koestler, Lucas A Salas, et al.
Clinical Epigenetics|October 29, 2022
Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarkerEmily Tang, John K Wiencke, Gayathri Warrier, et al.
Pageof 21